218 related articles for article (PubMed ID: 6364484)
1. Major histocompatibility complex restriction and transplantation immunity. A possible solution to the allograft problem.
Silvers WK; Bartlett ST; Chen HD; Fleming HL; Naji A; Barker CF
Transplantation; 1984 Jan; 37(1):28-32. PubMed ID: 6364484
[TBL] [Abstract][Full Text] [Related]
2. Influence of major-histocompatibility-complex-compatible and incompatible Langerhans cells on the survival of H-Y-incompatible skin grafts in rats.
Chen HD; Raab S; Silvers WK
Transplantation; 1985 Aug; 40(2):194-7. PubMed ID: 3895628
[TBL] [Abstract][Full Text] [Related]
3. Influence of the major histocompatibility complex (MHC) on the response to and expression of H-Y in rats.
Desquenne-Clark L; Chen HD; Silvers WK
Dev Genet; 1987; 8(4):189-94. PubMed ID: 3332253
[TBL] [Abstract][Full Text] [Related]
4. The influence of MHC-compatible and MHC-incompatible antigen-presenting cells on the survival of MHC-compatible cultured murine keratinocyte allografts.
Ramrakha PS; Sharp RJ; Yeoman H; Stanley MA
Transplantation; 1989 Oct; 48(4):676-80. PubMed ID: 2678636
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex semi-matching improves murine corneal allograft survival under oxidative macrophage dominancy.
Yamada J; Hamuro J; Terai K; Kinoshita S
Transplantation; 2007 Oct; 84(7):899-907. PubMed ID: 17984844
[TBL] [Abstract][Full Text] [Related]
6. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
Halliday GM; Odling KA; Muller HK
Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
[TBL] [Abstract][Full Text] [Related]
7. Studies on the behavior of H-Y incompatible skin grafts in rats.
Chen HD; Silvers WK
J Immunol; 1982 May; 128(5):2044-8. PubMed ID: 7037960
[TBL] [Abstract][Full Text] [Related]
8. Evidence for major histocompatibility complex restriction in transplantation immunity.
Silvers WK; Fleming HL; Naji A; Barker CF
Proc Natl Acad Sci U S A; 1982 Jan; 79(1):171-4. PubMed ID: 7033962
[TBL] [Abstract][Full Text] [Related]
9. Evidence that major histocompatibility complex restriction of foreign transplantation antigens occurs when tolerance is induced in neonatal mice and rats.
Desquenne-Clark L; Kimura H; Silvers WK
Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6265-7. PubMed ID: 3898083
[TBL] [Abstract][Full Text] [Related]
10. Recognition of an allograft.
Morris PJ
Nephrologie; 1986; 7(3 Suppl):19-22. PubMed ID: 3095671
[TBL] [Abstract][Full Text] [Related]
11. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
[TBL] [Abstract][Full Text] [Related]
12. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
Yamada J; Kurimoto I; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
[TBL] [Abstract][Full Text] [Related]
13. Influence of culturing on the functioning of major-histocompatibility-complex-compatible and incompatible islet grafts in diabetic mice.
Bartlett ST; Naji A; Silvers WK; Barker CF
Transplantation; 1983 Dec; 36(6):687-90. PubMed ID: 6419423
[TBL] [Abstract][Full Text] [Related]
14. Effect of neonatal spleen and thymus implants on H-Y incompatible skin grafts.
Skowron-Cendrzak A; Kubera M
Folia Biol (Krakow); 1989; 37(1-2):101-4. PubMed ID: 2673849
[TBL] [Abstract][Full Text] [Related]
15. Survival of organ-cultured islet allografts in partially major histocompatibility complex (MHC)-compatible mice.
Georgiou HM; Mandel TE
Transplant Proc; 1984 Aug; 16(4):1062-3. PubMed ID: 6431667
[No Abstract] [Full Text] [Related]
16. "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes.
Kupfer T; Beilke JN; Pham K; Buhrman J; Gill RG
Transplant Proc; 2008 Mar; 40(2):462-3. PubMed ID: 18374102
[TBL] [Abstract][Full Text] [Related]
17. Allograft rejection by T cell receptor transgenic mice.
Bassiri H; Markmann JF; Desai NM; Kim JI; Teh HS; Barker CF
J Surg Res; 1993 May; 54(5):437-44. PubMed ID: 8361170
[TBL] [Abstract][Full Text] [Related]
18. The effect of class I and class II alloantigens on skin allograft acceptance by lethally irradiated rats repopulated with syngeneic bone marrow.
Schwadron RB; Dittmer JE; Hartnett LC
Transplantation; 1985 May; 39(5):558-60. PubMed ID: 3887696
[No Abstract] [Full Text] [Related]
19. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
20. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
